Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent

Autor: Lars Jakobsen, Evald H. Christiansen, Phillip Freeman, Johnny Kahlert, Karsten Veien, Michael Maeng, Bent Raungaard, Julia Ellert, Steen D. Kristensen, Martin K. Christensen, Christian J. Terkelsen, Troels Thim, Ashkan Eftekhari, Rebekka V. Jensen, Nicolaj B. Støttrup, Anders Junker, Henrik S. Hansen, Lisette O. Jensen

Publikováno v: Jakobsen, L, Christiansen, E H, Freeman, P, Kahlert, J, Veien, K, Maeng, M, Raungaard, B, Ellert, J, Kristensen, S D, Christensen, M K, Terkelsen, C J, Thim, T, Eftekhari, A, Jensen, R V, Støttrup, N B, Junker, A, Hansen, H S & Jensen, L O 2023, ' Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent ', Catheterization and Cardiovascular Interventions, vol. 101, no. 1, pp. 13-21 . https://doi.org/10.1002/ccd.30480

OBJECTIVES: To compare the efficacy and safety of the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent (DTS) and the sirolimus-eluting Orsiro stent (O-SES) in patients with and without acute coronary syndrome (ACS) included in the SOR

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a328322cab723340935d6d4ac01587
https://pure.au.dk/portal/da/publications/impact-of-acute-coronary-syndrome-on-clinical-outcomes-after-revascularization-with-the-dualtherapy-cd34-antibodycovered-sirolimuseluting-combo-stent-and-the-sirolimuseluting-orsiro-stent(f41888cf-79e5-49c0-9b19-4854f821239d).html

Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent

Autor: Lars Jakobsen, Evald H. Christiansen, Phillip Freeman, Johnny Kahlert, Karsten Veien, Michael Maeng, Bent Raungaard, Julia Ellert, Steen D. Kristensen, Martin K. Christensen, Christian J. Terkelsen, Troels Thim, Ashkan Eftekhari, Rebekka V. Jensen, Nicolaj B. Støttrup, Anders Junker, Henrik S. Hansen, Lisette O. Jensen

Publikováno v: Jakobsen, L, Christiansen, E H, Freeman, P, Kahlert, J, Veien, K, Maeng, M, Raungaard, B, Ellert, J, Kristensen, S D, Christensen, M K, Terkelsen, C J, Thim, T, Eftekhari, A, Jensen, R V, Støttrup, N B, Junker, A, Hansen, H S & Jensen, L O 2022, ' Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent ', Catheterization and Cardiovascular Interventions, vol. 99, no. 7, pp. 1965-1975 . https://doi.org/10.1002/ccd.30175

OBJECTIVES: To compare the efficacy and safety of the dual therapy CD34 antibody-covered sirolimus-eluting Combo stent (DTS) and the sirolimus-eluting Orsiro stent (SES) in patients with and without diabetes mellitus (DM) included in the Scandinavian

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3842d975b26b865eaae4cffd0eb6e373
https://pubmed.ncbi.nlm.nih.gov/35384254

Clinical Outcomes following Large Vessel Coronary Artery Perforation Treated with Covered Stent Implantation: Comparison between Polytetrafluoroethylene- and Polyurethane-Covered Stents (CRACK-II Registry)

Autor: Wojciech Wojakowski, Brunon Tomasiewicz, Adrian Wlodarczak, Jerzy Bartuś, Andrzej Ochała, Malwina Smolarek-Nicpoń, Krzysztof Plens, Michalina Kołodziejczak, Monika Gruz-Kwapisz, Mariusz Gąsior, Sławomir Dobrzycki, Jan Jakub Kulczycki, Damian Hudziak, Miłosz Jaguszewski, Agnieszka Skoczyńska, Rafał Januszek, Tomasz Figatowski, Tomasz Pawłowski, Krzysztof Reczuch, Stanisław Bartuś, Wojciech Wańha, Mateusz Tajstra, Łukasz Kuźma

Publikováno v: Journal of Clinical Medicine; Volume 10; Issue 22; Pages: 5441
Journal of Clinical Medicine, Vol 10, Iss 5441, p 5441 (2021)
Journal of Clinical Medicine

Data on the clinical outcomes comparing synthetic fluorocarbon polymer polytetrafluoroethylene- (PTFE, GraftMaster) and polyurethane- (Papyrus) covered stents (CSs) to seal coronary artery perforations (CAPs) are limited. We aimed to evaluate 30-day

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf6debdc671bad70f9b9597356dcfef5
https://doi.org/10.3390/jcm10225441

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.